Researchers identify a promising new strategy for glaucoma cell replacement therapy

Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment.

Related Keywords

United States ,Massachusetts ,America ,Petr Baranov ,Emil Kriukov ,Jonathanr Soucy ,Levi Todd ,John Dayron Rivera ,Volhav Malechka ,University Of Washington ,National Eye Institute ,Gilbert Family Foundation ,National Institutes Of Health ,Schepens Eye Research Institute Of Mass ,Ophthalmology At Harvard Medical School ,Bright Focus Foundation ,Schepens Eye Research Institute ,Mass Eye ,National Academy ,Harvard Medical ,Monichan Phay ,National Institutes ,Gilbert Family ,Ear ,Eye ,Glaucoma ,Stem Cells ,Blindness ,Flood ,Fell ,Chemokines ,Ganglion ,Medical School ,Neck ,Ophthalmology ,Research ,Technology ,Throat ,Vision Loss ,